New hope for kids with short bowel: can a drug cut the need for IV feeding?

NCT ID NCT07319832

Recruiting now Disease control Sponsor: Takeda Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a drug called teduglutide can help children aged 1 to 17 with short bowel syndrome reduce the amount of nutrition they get through a vein. The study will review past medical records and collect new data from about 12 children in China. The goal is to see if the drug can safely lower or even stop the need for IV nutrition.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SHORT BOWEL SYNDROME (SBS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

short bowel syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SHORT BOWEL SYNDROME (SBS)

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Children's Hospital Zhejiang University School of Medicine
NOT_YET_RECRUITING

Hangzhou, Zhejiang, 310006, China

Contact
Guangzhou Women And Children's Medical Center
NOT_YET_RECRUITING

Guangzhou, Guangdong, 510040, China

Contact
Shanghai Children's Hospital
NOT_YET_RECRUITING

Shanghai, Shanghai Municipality, 200062, China

Contact
Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
RECRUITING

Shanghai, Shanghai Municipality, 200092, China

Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.